Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...

The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna ...

In the world of biotechnology, few stories resonate as strongly as that of Pasithea Therapeutics Corp. (NASDAQ: KTTA). On Thursday, the stock saw an impressive surge of +80.31%, reaching $6.90 during ...

If these preliminary findings are more widely applicable, opioid use disorder would be added to the long list of ailments potentially reduced by Ozempic.

West Australians could be the first to be treated for a common but life-threatening disease that often leads to heart attacks, limb amputations and even death. Current medications do not provide a ...

Eli Lilly is investing $1.8 billion to expand production in Ireland of its Alzheimer's treatment and weight-loss drugs. The company's Alzheimer's drug, Kisunla, was approved by the U.S. Food and ...

Nonetheless, researchers are hoping to see the global impact of the drug in places where treatment is lacking. “In the United States, the stubbornly high rate of HIV diagnoses — especially ...

The funding will be directed towards rehabilitation and community reintegration efforts, with $15.9 million allocated for capital works and $4.1 million for operational expenses. Corrections Minister ...

After missing nearly two months with a nagging calf injury, shortstop Bo Bichette began a rehab assignment with triple-A Buffalo on Tuesday, going 1-for-3 with a single in his first game since ...

After a long hard-fought game, the Patriots ended up pulling out ... Following his big-time performance, White was selected for a "random" drug test, he announced on his Instagram.

FOXBORO -- On Sunday, Keion White had a monster game for the Patriots in the team's Week 1 win over the Cincinnati Bengals. On Monday, the NFL made him take a drug test. "The boys got me on my day ...